In: Orth-Gomér K, Schneiderman N (eds) Behavior Medicine Approaches to cardiovascular disease prevention. Lawrence Erlbaum Associates, Hillsdale, pp 69–85 https://www.selleckchem.com/products/KU-55933.html Theorell T, Perski A, Åkerstedt T, Sigala F, Ahlberg-Hultén

Verubecestat chemical structure G, Svensson J, Eneroth P (1988) Changes in job strain in relation to changes in physiological state—a longitudinal study. Scand J Work Environ Health 14:189–196CrossRef Theorell T, Hartzell M, Näslund S (2009) Brief report. A note on designing evaluations of health effects of cultural activities at work. Arts Health 1:89–92 Wikström BM (1994). Pleasant guided mental walks via pictures of works of art. Academic thesis, Karolinska Institutet, Stockholm”
“Introduction Nonspecific low back pain (LBP) is very common. Two large population studies (Papageorgiou et al. 1995; Cote et al. 1998) place a lifetime prevalence of back pain at 60–80 %. This high prevalence has considerable impact within the employment sector. For example, in a study of back pain consulters from a UK primary care sample (Wynne-Jones et al. 2008), 37 % of those unemployed attributed this to their back pain, 22 % of those currently employed were on sickness absence and a further 11 % were on reduced duties at work due to their back pain. A recent report by the European Work Foundation ‘Fit for work’ (Bevan et al. 2009) reports that 25 % of workers in Europe suffer {Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|buy Anti-infection Compound Library|Anti-infection Compound Library ic50|Anti-infection Compound Library price|Anti-infection Compound Library cost|Anti-infection Compound Library solubility dmso|Anti-infection Compound Library purchase|Anti-infection Compound Library manufacturer|Anti-infection Compound Library research buy|Anti-infection Compound Library order|Anti-infection Compound Library mouse|Anti-infection Compound Library chemical structure|Anti-infection Compound Library mw|Anti-infection Compound Library molecular weight|Anti-infection Compound Library datasheet|Anti-infection Compound Library supplier|Anti-infection Compound Library in vitro|Anti-infection Compound Library cell line|Anti-infection Compound Library concentration|Anti-infection Compound Library nmr|Anti-infection Compound Library in vivo|Anti-infection Compound Library clinical trial|Anti-infection Compound Library cell assay|Anti-infection Compound Library screening|Anti-infection Compound Library high throughput|buy Antiinfection Compound Library|Antiinfection Compound Library ic50|Antiinfection Compound Library price|Antiinfection Compound Library cost|Antiinfection Compound Library solubility dmso|Antiinfection Compound Library purchase|Antiinfection Compound Library manufacturer|Antiinfection Compound Library research buy|Antiinfection Compound Library order|Antiinfection Compound Library chemical structure|Antiinfection Compound Library datasheet|Antiinfection Compound Library supplier|Antiinfection Compound Library in vitro|Antiinfection Compound Library cell line|Antiinfection Compound Library concentration|Antiinfection Compound Library clinical trial|Antiinfection Compound Library cell assay|Antiinfection Compound Library screening|Antiinfection Compound Library high throughput|Anti-infection Compound high throughput screening| from back pain and estimate the total cost of musculoskeletal illness on employment productivity

in Europe at €12 billion. This is further compounded by evidence that the longer a person is out of work due to back pain, the more difficult it is to re-engage into employment, and that recurrence rates are high (Waddell and Burton 2001). In the light of the impact of back pain on employment, there has been a steady growth in interest in what employment factors impact on both risk for back pain and related outcomes such as sickness absence, ifoxetine recovery and return to work (Hartvigsen et al. 2004; Steenstra et al. 2005). One influential theoretical model, utilised within employment and illness research, is

Karasek’s Demand Control Model (Karasek et al. 1998). According to the model having a job with high demands (e.g. high paced physical work), with no or little control over the decisions affecting work (e.g. fixed schedules, having a subordinate position), leads to an increase in stress and subsequent illness (Landsbergis et al. 2001). It is proposed that these outcomes can be modified if the person receives social support within the employment context (Johnson and Hall 1988; Theorell and Karasek 1996). This and similar theoretical models have been investigated within musculoskeletal research (Bongers et al. 2006) and have led to clinical guidelines on the consideration of work psychosocial factors (Costa-Black et al. 2010). However, the evidence within systematic reviews on the impact of employment social support on back pain has been conflicting.